Verrica Pharmaceuticals Inc - fluxo de caixa (NASDAQ:VRCA) | MetaTrader

Abrir gráfico completo

Financials

Visão geral Relatórios Estatísticas

Cash from operating activities -30.21 M-27.58 M-18.65 M-38.58 M-60.93 M-17.63 M -17.63 M Cash from investing activities -3.58 M-998 K54.04 M-362 K-19 K0 — Cash from financing activities 35.23 M33.65 M-16.87 M74.21 M37.73 M1.45 M 1.45 M Free cash flow -31.68 M-28.46 M-18.95 M-38.94 M-60.95 M-17.63 M -17.63 M

Notícias

Verrica Pharmaceuticals Inc. (VRCA) Q4 2025 Earnings Call Transcript

Ações da Verrica Pharmaceuticals sobem após lançamento do YCANTH no Japão

Verrica Pharmaceuticals stock rises after partner launches YCANTH in Japan

Verrica’s partner launches molluscum treatment in Japan

Verrica Pharmaceuticals (VRCA) Upgraded to Strong Buy: Here's Why

New Strong Buy Stocks for February 2nd

How Much Upside is Left in Verrica Pharmaceuticals (VRCA)? Wall Street Analysts Think 97.11%

Ações da Verrica Pharmaceuticals sobem após TD Cowen reiterar recomendação de compra

Verrica Pharmaceuticals stock advances as TD Cowen reiterates Buy rating

Verrica dosa primeiro paciente em estudo de fase 3 para tratamento de verrugas comuns

Verrica doses first patient in phase 3 trial for common wart treatment

Verrica Pharmaceuticals nomeia Charles Frantzreb para o conselho e aprova concessões de ações